Alkermes (ALKS) Net Equity Issued and Repurchased (2014)
Alkermes (ALKS) posted quarterly Net Equity Issued and Repurchased of $248.4 million for Q1 2014.
Alkermes (ALKS) Net Equity Issued and Repurchased (2014) Analysis & Trends
Alkermes (ALKS) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $248.4 million the latest figure, recorded in Q1 2014.
- In Q1 2014, Net Equity Issued and Repurchased changed N/A year-over-year to $248.4 million; the TTM figure through Dec 2014 stood at $248.4 million (changed N/A YoY), while the FY2014 annual figure was $248.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased held at $248.4 million in Q1 2014 per ALKS's latest filing.
- Across five years, Net Equity Issued and Repurchased topped out at $248.4 million in Q1 2014 and bottomed at $248.4 million in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 248.41 Mn |
| Mar 31, 2014 | 248.41 Mn |